Stock Earnings

Question 1

What are Regenxbio Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Regenxbio Inc has a total asset of $465, Net loss of $-227

Question 2

What are the key financial ratios for RGNX?

Accepted Answer

Regenxbio Inc's Current ratio is 2.25, has a Net margin is -273.49, sales per share of $1.67.

Question 3

How is Regenxbio Inc's revenue broken down by segment or geography?

Accepted Answer

Regenxbio Inc largest revenue segment is Gene Therapy, at a revenue of 90,242,000 in the most earnings release.For geography, International is the primary market for Regenxbio Inc, at a revenue of 61,364,560.

Question 4

Is Regenxbio Inc profitable?

Accepted Answer

no, according to the latest financial statements, Regenxbio Inc has a net loss of $-227

Question 5

Does Regenxbio Inc have any liabilities?

Accepted Answer

yes, Regenxbio Inc has liability of 206

Question 6

How many outstanding shares for Regenxbio Inc?

Accepted Answer

Regenxbio Inc has a total outstanding shares of 49.54

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	155	83	90	112	470	154
Revenue Growth (YoY)	74%	-8%	-20%	-76%	204.99%	340%
Cost of Revenue	27	33	37	54	51	35
Gross Profit	128	49	53	58	418	118
Selling, General & Admin	74	71	88	85	79	63
Research & Development	217	208	232	242	181	166
Operating Expenses	293	280	321	321	258	238
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-175	-227	-263	-280	141	-106
Income Tax Expense	--	--	0	0	13	5
Net Income	-175	-227	-263	-280	127	-111
Net Income Growth	-27%	-14%	-6%	-320%	-214%	18%
Shares Outstanding (Diluted)	51.48	49.5	43.73	43.2	43.9	37.3
Shares Change (YoY)	2%	13%	1%	-2%	18%	2%
EPS (Diluted)	-3.41	-4.58	-6.02	-6.5	2.91	-2.98
EPS Growth	-28%	-24%	-7%	-323%	-198%	16%
Free Cash Flow	-90	-175	-228	-238	134	-81
Free Cash Flow Per Share	-1.74	-3.53	-5.21	-5.5	3.05	-2.17
Gross Margin	82.58%	59.03%	58.88%	51.78%	88.93%	76.62%
Operating Margin	-105.8%	-277.1%	-297.77%	-233.92%	34.04%	-77.27%
Profit Margin	-112.9%	-273.49%	-292.22%	-250%	27.02%	-72.07%
Free Cash Flow Margin	-58.06%	-210.84%	-253.33%	-212.5%	28.51%	-52.59%
EBITDA	-149	-214	-251	-250	169	-111
EBITDA Margin	-96.12%	-257.83%	-278.88%	-223.21%	35.95%	-72.07%
D&A For EBITDA	15	16	17	12	9	8
EBIT	-164	-230	-268	-262	160	-119
EBIT Margin	-105.8%	-277.1%	-297.77%	-233.92%	34.04%	-77.27%
Effective Tax Rate	--	--	0%	0%	9.21%	-4.71%

Regenxbio Inc (RGNX) Price

RGNX Stock Price Chart

RGNX Income

Follow-Up Questions